Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biosyent Inc (TSE:RX)
TSXV:RX
Holding TSE:RX?
Track your performance easily
RX Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$7.66 - C$11.45
Previous CloseC$10.75
Volume2.92K
Average Volume (3M)5.72K
Market Cap
C$126.76M
Enterprise ValueC$101.80M
Total Cash (Recent Filing)C$26.19M
Total Debt (Recent Filing)C$1.22M
Price to Earnings (P/E)17.6
Beta0.16
Next Earnings
Nov 14, 2024EPS Estimate
C$0.14Last Dividend Ex-Date
Sep 04, 2024Dividend Yield1.58%
Share Statistics
EPS (TTM)0.61
Shares Outstanding11,586,914
10 Day Avg. Volume3,294
30 Day Avg. Volume5,717
Standard Deviation0.08
R-Squared0.26
Alpha0.00789
Financial Highlights & Ratios
Price to Book (P/B)3.62
Price to Sales (P/S)3.94
Price to Cash Flow (P/CF)46.10
P/FCF Ratio49.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$11.00Price Target Upside1.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Biosyent News
PremiumCompany Announcements
BioSyent Maintains Dividend, Signals Growth
PremiumCompany Announcements
BioSyent Reports Record Sales and Strategic Growth in 2024
PremiumPress Releases
BioSyent Declares Third Quarter 2024 DividendPremiumPre-Earnings
Is RX a Buy, Before Earnings?
PremiumCompany Announcements
BioSyent Expands Portfolio with New Endocrinology Product
Options Prices
Currently, No data available
---
Ownership Overview
60.63% Insiders
0.41% Mutual Funds
<0.01% Other Institutional Investors
38.96% Public Companies and
Individual Investors
RX FAQ
What was Biosyent Inc’s price range in the past 12 months?
Biosyent Inc lowest stock price was C$7.66 and its highest was C$11.45 in the past 12 months.
What is Biosyent Inc’s market cap?
Currently, no data Available
When is Biosyent Inc’s upcoming earnings report date?
Biosyent Inc’s upcoming earnings report date is Nov 14, 2024 which is in 55 days.
How were Biosyent Inc’s earnings last quarter?
Biosyent Inc released its earnings results on Aug 26, 2024. The company reported C$0.13 earnings per share for the quarter, the consensus estimate of C$0.13 by C$0.
Is Biosyent Inc overvalued?
According to Wall Street analysts Biosyent Inc’s price is currently Undervalued.
Does Biosyent Inc pay dividends?
Biosyent Inc pays a Quarterly dividend of C$0.04 which represents an annual dividend yield of 1.58%. See more information on Biosyent Inc dividends here
What is Biosyent Inc’s EPS estimate?
Biosyent Inc’s EPS estimate is C$0.14.
How many shares outstanding does Biosyent Inc have?
Biosyent Inc has 11,791,844 shares outstanding.
What happened to Biosyent Inc’s price movement after its last earnings report?
Biosyent Inc reported an EPS of C$0.13 in its last earnings report, expectations of C$0.13. Following the earnings report the stock price went up 3.835%.
Which hedge fund is a major shareholder of Biosyent Inc?
Currently, no hedge funds are holding shares in TSE:RX
---
Biosyent Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$11.00 (1.38% Upside)
C$11.00 (1.38% Upside)
Insider Transactions
Sold Shares
Worth C$5.1M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
39.57%
12-Months-Change
Fundamentals
Return on Equity
20.88%
Trailing 12-Months
Asset Growth
4.97%
Trailing 12-Months
Company Description
Biosyent Inc
Biosyent Inc is a specialty pharmaceutical company engaged in developing pharmaceutical and healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System and Cysview. The company through its subsidiaries sources acquires or in-licenses pharmaceutical products and markets the products. Geographically all the activities are functioned through the region of Canada.
---
RX Stock 12 Month Forecast
Average Price Target
C$11.00
▲(1.38% Upside)
Technical Analysis
Best Analysts Covering RX
1 Year
1 Year Success Rate
4/4 ratings generated profit
1 Year Average Return
+20.82%
assigned a buy rating 24 days ago
Copying David Martin PhD's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +20.82% per trade.
---